Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
S&W Seed Company is a commercial agricultural seed and crop genetics company focused on breeding, producing, processing, and selling proprietary seeds rather than human therapeutics. Its portfolio centers on alfalfa and sorghum, and also includes sunflower, stevia, camelina, wheat, forage cereals, pasture seeds, and related germplasm. The company has emphasized its Double Team sorghum herbicide-trait system and camelina development for biofuel feedstocks, alongside a broad international seed business. S&W operates primarily in the United States, Australia, and other international markets through seed production, processing, distribution, and trait licensing activities. Although it is sometimes screened alongside life-science businesses because of its genetics and trait-development work, it is an agriculture company rather than a biotech/pharma/healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on S&W Seed Company.